Asia Pacific Biosimilar Market - Size
Base Year For Estimation
2023
Forecast Data Period
2024-2030
Historical Data Period
2018-2021
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
Biosimilar or follow-on-biologics are similar to the brand biopharmaceutical drugs which are synthetic versions of original products. Biosimilars have a patent expiration, and their developments are the crucial part of the overall growth of biosimilar market. Biosimilars are derived from yeast, animals, bacteria, plants, and viruses.
Asia Pacific Biosimilars Market Segments Size & Growth:
Asia Pacific Biosimilars Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are next-gen business, high growth in chronic diseases, and less cost biosimilar drugs. However, high initial investments in research hinder the growth of the protein expression market.
Asia Pacific Biosimilars Market Segments Share:
Asia Pacific Biosimilars Market is categorised into by-product which consists of insulin, interferon, human growth hormone, and granulocyte colony-stimulating factor. Granulocyte colony-stimulating factor has the most significant share as they are cheaper compared to others. By services, Asia Pacific biosimilars market is segmented into clinical trials
Asia Pacific Biosimilar Market - Growth
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
and contract research and manufacturing services. Among all clinical trials are expected to have high growth rate during the forecast period 2018-2024, due to increase in demand for low-cost drugs and vaccines that can treat various chronic diseases. The technology is segregated into chromatography, recombinant DNA technology, monoclonal antibodies technology, and nuclear magnetic resonance technology. Monoclonal antibodies technology is expected to have the most significant share in the market due to treating chronic diseases in a single operation
Blood disorders and autoimmune disease are leading in biosimilars among applications owing to the change in patent scenario and high-rated biologics. By Geography, China is dominating the biosimilars market, and the growth in the Asia Pacific is mainly attributed because of the favourable government’s regulations. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising chronic diseases, adoption of biosimilar drugs and investment in R&D research.
Asia Pacific Biosimilars Market Segments Trends:
- Emerging technology in biosimilars market is stem cell technology in Asia Pacific
You can also purchase parts of this report. Do you want to check out a section wise price list
Asia Pacific Biosimilar Market - Porter's Five Force Analysis
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
region.
In a recent study, biosimilar drugs will cut down the cost of biologics which helps in treating diseases like cancer and other chronic disorders intern replace the biologics in the market.
In January 2018, Novartis and Biocon have developed their biosimilar drug for the next generation in immunology and oncology.
Asia Pacific Biosimilars Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Hexal
- Zydus Cadila Healthcare
- Novartis/Sandoz
- Apotex
- Samsung Bioepis
Exclusive Benefits
Credibility and
Transparency
We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.
Exhaustive
Coverage
Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.
Competitive
Edge
Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.
Golden
pportunities
Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.
Top-notch Reportsd
Guaranteed
Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.
Post Purchase
Support
Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.
